Supplements

What Happens to RDW in Pregnancy?

RDW quietly climbs during pregnancy and most women never get a clear explanation of why. A rising RDW can signal nutrient gaps — particularly iron and folate — before anemia even shows up on a CBC. Understanding what's normal versus concerning can make a real difference for maternal and fetal health.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
RDW in pregnancyred cell distribution widthpregnancy lab markersiron deficiency pregnancyprenatal nutrition
What Happens to RDW in Pregnancy?

What Happens to RDW in Pregnancy?

RDW typically rises during pregnancy, often moving from a normal pre-pregnancy range of 11.5–14.5% toward the upper end or just above it. This happens because pregnancy dramatically increases demand for iron and folate, and even mild shortfalls produce a mix of large and small red blood cells — exactly what a high RDW captures. The main caveat: a modestly elevated RDW (up to about 15–16%) in a well-nourished pregnant woman may be physiologically expected, while values above that — especially alongside low hemoglobin or low MCV — usually warrant further investigation.

---

Understanding RDW: The Red Cell Width Metric That Often Gets Ignored

Red Cell Distribution Width (RDW) measures the variation in the size of your red blood cells. A low RDW means your red cells are remarkably uniform; a high RDW means they vary considerably in size — a state called anisocytosis. It is reported as a percentage (RDW-CV) or as an absolute measurement in femtoliters (RDW-SD), with RDW-CV being more commonly listed on standard lab panels.

For non-pregnant adults, the reference range for RDW-CV is roughly 11.5–14.5%. Outside of pregnancy, a persistently elevated RDW is associated with iron deficiency anemia, vitamin B12 or folate deficiency, hemolytic conditions, and even cardiovascular risk (Lippi et al., Clinical Chemistry and Laboratory Medicine 2010; PMID: 20604720).

During pregnancy, RDW does not behave the same way it does outside of it. The physiological changes of gestation — a 40–50% expansion in plasma volume, accelerated erythropoiesis, and profoundly increased micronutrient demand — create a context in which RDW naturally shifts upward even in otherwise healthy pregnancies.

If you are curious how RDW compares to other markers on your panel, understanding what RDW tells you about your hormones provides useful context for interpreting results outside of pregnancy as well.

---

Why RDW Rises During Pregnancy: The Physiology

Several overlapping mechanisms drive RDW upward across the three trimesters:

1. Plasma volume expansion outpaces red cell mass

By the late second trimester, plasma volume has expanded by roughly 40–50%, while red blood cell mass increases by only about 20–30%. This hemodilution lowers hemoglobin concentration and can expose underlying variability in red cell size that was previously masked (Soma-Pillay et al., Cardiovascular Journal of Africa 2016; PMID: 26915589).

2. Iron demand surges

Total iron requirements during pregnancy are approximately 1,000 mg — far exceeding what most dietary patterns deliver. The fetus and placenta preferentially draw iron, and maternal stores are often depleted first. When iron supply is insufficient, the bone marrow produces smaller, hypochromic red blood cells alongside older, larger ones — a hallmark pattern that widens RDW. You can review how other markers track alongside this shift in what happens to hemoglobin during pregnancy.

3. Folate requirements nearly double

The recommended folate intake jumps from 400 mcg DFE pre-pregnancy to 600 mcg DFE during pregnancy (and higher in multifetal gestation). Folate-deficient erythropoiesis produces macrocytes — abnormally large red cells — that co-exist with normal or small cells, again widening the distribution. The postpartum period creates its own folate challenges, described in detail in what happens to folate levels in the postpartum period.

4. Vitamin B12 falls with hemodilution

Plasma B12 levels decline during pregnancy partly due to dilution and partly due to active placental transfer. Insufficient B12 impairs DNA synthesis in developing red cells, contributing to macrocytosis and an elevated RDW.

5. Chronic low-grade inflammation

Pregnancy is an immunologically distinct state, and CRP often rises modestly even without infection. Inflammatory cytokines suppress erythropoiesis and alter red cell lifespan, adding further heterogeneity to the circulating red cell pool. For more on how inflammatory markers shift, see what happens to CRP levels during pregnancy.

---

What Is a Normal RDW Level in Pregnancy?

There is no universal obstetric-specific RDW reference range, which is part of what makes this marker tricky to interpret. Most laboratories apply the standard non-pregnant adult range (11.5–14.5%) to pregnant patients without adjustment.

Published research suggests the following general observations:

TrimesterExpected RDW-CV Range (approximate)Common Driver
First11.5–14.0%Near-baseline; plasma expansion just beginning
Second12.5–15.5%Hemodilution + accelerating iron demand
Third13.0–16.5%Peak iron and folate demands; mixed cell populations

A study of pregnant women in India found that mean RDW was significantly higher in pregnant women compared to non-pregnant controls at all trimesters, peaking in the third trimester, particularly in women with iron deficiency anemia (Tiwari et al., Journal of Clinical and Diagnostic Research 2013). The take-home: a value that would be flagged as elevated in a standard blood panel may be physiologically expected in the third trimester of a nutritionally replete pregnancy.

For a dedicated breakdown of reference ranges, what is a normal RDW level in pregnancy covers trimester-specific data in greater depth.

---

When a High RDW in Pregnancy Is Clinically Meaningful

Not every elevated RDW in pregnancy requires intervention, but certain patterns should prompt further workup:

  • RDW above 16–17% in any trimester, especially if trending upward on serial CBCs
  • High RDW + low MCV (microcytosis): Classic iron deficiency pattern — the bone marrow is producing smaller cells, but older larger cells persist in circulation
  • High RDW + high MCV (macrocytosis): Suggests B12 or folate deficiency, or less commonly a hemolytic process
  • High RDW + low hemoglobin: Signals frank anemia, not just nutritional strain
  • High RDW alongside abnormal thyroid markers: Thyroid dysfunction can impair erythropoiesis independently of nutritional status; thyroid antibody changes in pregnancy add another layer of complexity

A large population-based cohort (n = 3,529 deliveries) found that elevated maternal RDW in the third trimester was independently associated with adverse perinatal outcomes including low birth weight and preterm delivery, after adjusting for hemoglobin and other confounders (Patel et al., Journal of Maternal-Fetal and Neonatal Medicine 2018; PMID: 28367672). This suggests RDW carries prognostic information beyond what hemoglobin alone captures.

---

The Nutrient Deficiencies Most Likely Driving a High RDW in Pregnancy

Iron

Iron deficiency is the most common nutritional deficiency in pregnancy worldwide. The WHO estimates that roughly 40% of pregnant women are anemic globally, with iron deficiency accounting for the majority of cases. Ferritin below 30 ng/mL is an early signal of depleted stores, often preceding any change in hemoglobin. RDW rises as the first morphological clue that red cell production is becoming iron-limited.

Folate

Folate is essential for DNA synthesis in rapidly dividing erythroid precursors. Even borderline insufficiency — serum folate drifting toward the lower end of the normal range — can impair the uniformity of red cell maturation. Methyltetrahydrofolate (MTHF) is the bioactive form relevant for women with MTHFR polymorphisms, who may convert dietary and synthetic folate less efficiently.

Vitamin B12

B12 deficiency is underdiagnosed in pregnancy, particularly in vegetarian and vegan women. Because B12 and folate work in related pathways (both are required for homocysteine remethylation), a deficiency in either — or both — leads to megaloblastic changes and a rising RDW.

Zinc

Zinc plays a supporting role in erythropoiesis and immune regulation. Zinc levels fall across pregnancy, partly due to hemodilution and partly due to fetal uptake. The implications of this shift are covered in what happens to zinc levels during pregnancy. While zinc deficiency alone rarely causes a dramatic RDW shift, it can compound iron and folate shortfalls.

---

Can You Bring RDW Down During Pregnancy?

If the elevated RDW is driven by a correctable nutritional gap — which it usually is — yes. The approach is targeted repletion, not generic supplementation.

For iron deficiency:

Iron supplementation at doses of 60–120 mg elemental iron per day has been shown to reduce RDW in pregnant women with documented iron deficiency anemia over 8–12 weeks of treatment (Peña-Rosas et al., Cochrane Database of Systematic Reviews 2015; PMID: 26599679). The form matters: ferrous bisglycinate chelate is better tolerated and absorbed at lower doses than ferrous sulfate.

For folate:

Supplementation with 400–1,000 mcg of methylfolate or folic acid restores folate-dependent erythropoiesis within 4–8 weeks in deficient individuals. MTHF forms are preferred for women who have identified MTHFR variants.

For B12:

Methylcobalamin at doses of 500–1,000 mcg daily is the preferred supplemental form, particularly for women with absorption concerns or plant-based diets.

General strategies for improving RDW through nutrition and lifestyle are covered in how to improve RDW naturally.

---

What This Means for Your Formula

Personalized supplementation matters precisely because a high RDW during pregnancy can have different root causes in different women. A vegan woman with low B12 needs a very different formula than a meat-eater whose ferritin has quietly dropped across the second trimester.

Ones approaches this by analyzing lab data — including complete blood count markers, ferritin, B12, folate, and thyroid values — alongside dietary patterns and health history to identify which nutritional gaps are actually driving an individual's markers. Rather than recommending a standard prenatal formula, the AI practitioner pinpoints the specific shortfalls and builds a targeted capsule plan around them.

For RDW concerns specifically, Ones may include:

  • Iron (as ferrous bisglycinate chelate): A highly bioavailable, gentle form dosed to individual need based on ferritin and hemoglobin values — not a one-size-fits-all 18 mg prenatal dose
  • Methylfolate (5-MTHF): The bioactive folate form, relevant for the significant proportion of women who carry MTHFR variants that impair conversion of synthetic folic acid
  • Zinc: Dosed to support erythropoiesis and immune function at levels calibrated to lab-confirmed zinc status, complementing the iron and folate repletion strategy

The formula is built within a 6 or 9-capsule daily plan — selected by the AI based on the number and severity of identified gaps — so the final formula reflects your actual findings, not a generic prenatal checklist.

---

Key Takeaways

  • RDW typically rises during pregnancy, driven by hemodilution, surging iron and folate demands, and the production of mixed red cell populations
  • A modestly elevated RDW (up to 15–16%) may be physiologically normal in the second or third trimester of an otherwise healthy pregnancy — but values above that, or rising trends, warrant investigation
  • High RDW + low MCV points toward iron deficiency; high RDW + high MCV suggests folate or B12 insufficiency — the combination tells you more than RDW alone
  • Targeted repletion works: Correcting the underlying nutritional gap — with the right form and dose of iron, folate, or B12 — typically normalizes RDW within 8–12 weeks
  • RDW carries independent prognostic value in pregnancy: elevated third-trimester RDW is associated with adverse perinatal outcomes even after accounting for hemoglobin
  • Consult your healthcare provider before beginning or changing any supplementation during pregnancy — personalized lab review is essential for safe, effective support

---

Always discuss lab results and supplement decisions with your OB, midwife, or a qualified healthcare provider. The information in this article is educational and does not constitute medical advice.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading